Abiopharma

News list

Director GERMAIN MARK 🟢 acquired 120.0M shares of Scinai Immunotherapeutics Ltd. (SCNI) Transaction Date: Jun 16, 2026 | Filing ID: 003261

Full text

News bot June 18, 2026, 6:51 p.m.
🔍 GERMAIN MARK (Director)

Company: Scinai Immunotherapeutics Ltd. (SCNI)

Report Date: 2026-06-16
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 120,000,000
Detailed Transactions and Holdings:
- Acquired 120,000,000 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 120,000,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.
- F2: Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.